Company Search:
Advanced Search
Sponsored Links
Helix Biopharma Corp Company Snapshot
Helix Biopharma Corp operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Helix Biopharma Corp with three other companies in this sector in Canada: Diagnocure Inc. (2012 sales of 2.47 million Canadian Dollars [US$1.89 million] of which 100% was Biotechnologies), Ceapro Inc. (5.17 million Canadian Dollars [US$3.94 million] ), and Medicure Inc (4.80 million Canadian Dollars [US$3.66 million] of which 100% was Pharmaceutical Products).

Sales Analysis. Helix Biopharma Corp reported sales of C$4.26 million (US$3.25 million) for the fiscal year ending July of 2012. This represents a decrease of 6.0% versus 2011, when the company's sales were C$4.53 million.
  Stock Performance Chart for Helix Biopharma Corp
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 1.55
(Figures in Canadian Dollars)
1 Week -10.4%   13 Weeks -18.4%  
4 Weeks -16.7%   52 Weeks -25.8%  
Helix Biopharma Corp Key Data:
  Ticker: HBP Country: Canada
  Exchanges: TOR FRA Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2012 Sales 4,260,000
(Year Ending Jan 2013).
Employees: 13
  Currency: Canadian Dollars Market Cap: 139,209,781
  Fiscal Yr Ends: July Shares Outstanding: 89,812,762
  Share Type: Common Closely Held Shares: 10,522,300
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.